Australia markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
50.77+0.38 (+0.75%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
37,369,000
37,369,000
37,631,000
35,677,000
36,204,000
Cost of revenue
12,157,000
12,157,000
11,976,000
11,435,000
11,611,000
Gross profit
25,212,000
25,212,000
25,655,000
24,242,000
24,593,000
Operating expenses
Research development
5,529,000
5,529,000
6,018,000
5,894,000
5,472,000
Selling general and administrative
9,390,000
9,390,000
9,883,000
9,859,000
10,058,000
Total operating expenses
17,319,000
17,319,000
18,429,000
17,987,000
17,392,000
Operating income or loss
7,893,000
7,893,000
7,226,000
6,255,000
7,201,000
Interest expense
436,000
436,000
444,000
435,000
420,000
Total other income/expenses net
6,248,000
6,248,000
-4,101,000
-1,579,000
-1,398,000
Income before tax
13,804,000
13,804,000
2,822,000
4,405,000
5,530,000
Income tax expense
1,813,000
1,813,000
139,000
481,000
1,722,000
Income from continuing operations
12,350,000
12,350,000
2,938,000
4,423,000
3,912,000
Net income
12,314,000
12,314,000
2,806,000
4,306,000
8,434,000
Net income available to common shareholders
12,314,000
12,314,000
2,806,000
4,306,000
8,434,000
Basic EPS
-
-
1.12
1.73
3.35
Diluted EPS
-
-
1.12
1.73
3.35
Basic average shares
-
-
2,499,800
2,494,200
2,513,800
Diluted average shares
-
-
2,499,800
2,494,200
2,513,800
EBITDA
-
17,924,000
10,718,000
9,119,000
9,636,000